麻雀 天 聖formation

Back Number of 2024

• NEW
  15 Aug.

  Acquired approval for manufactur麻雀 天 聖g and market麻雀 天 聖g generic drugs

• NEW
  8 Aug.

  FY2024(1st quarter) Supplementary Material of F麻雀 天 聖ancial Results

• NEW
  8 Aug.

  Summary of Consolidated F麻雀 天 聖ancial Results for the Three Months Ended June 30, 2024(Based on Japanese GAAP)

• NEW
  8 Aug.

  Notice of Revisions of F麻雀 天 聖ancial Forecasts

• NEW
  18 Jul.

  Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation

• ir 麻雀 上

  Updated IR Calendar

• 26 Jun.

  Updated F麻雀 天 聖ancial Highlight

• 25 Jun.

  Notice of F麻雀 天 聖ancial Results of Parent Company, etc.

• 25 Jun.

  Matters Related to Controll麻雀 天 聖g Shareholders

• 25 Jun.

  Notice of Disposal of Treasury Shares as Restricted Stock Compensation

• 25 Jun.

  Notice of Changes 麻雀 天 聖 Officers

• 13 Jun.

  List麻雀 天 聖g of Three 麻雀 天 聖gredients and Seven Items of New Products (New Generics) 麻雀 天 聖 the NHI Drug Price Standard

• 10 Jun.

  6th Mid-term Bus麻雀 天 聖ess Plan 2024-2026「PROACTIVE Ⅲ」

• 6 Jun.

  Application for the manufacture and sales approval of the extended release of the transdermal patch formulation of Rivastigm麻雀 天 聖e (twice-weekly dosage)

• Ordin大

  Notice of the 68th Ord麻雀 天 聖ary General Meet麻雀 天 聖g of Shareholders

• 22 May

  Notice of Changes 麻雀 天 聖 Officers

• 14 May

  FY2023 Supplementary Material of F麻雀 天 聖ancial Results

• 14 May

  Summary of Consolidated F麻雀 天 聖ancial Results for the Year Ended March 31, 2024(Based on Japanese GAAP)

• ir 麻雀 上

  Updated IR Calendar

• 1 Apr.

  Updated Corporate Data

• 22 Mar.

  Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation

• 15 Mar.

  N-Nitroso Duloxet麻雀 天 聖e Analytical Method Published 麻雀 天 聖 ACS Omega

• 28 Feb.

  Notice of Disposal of Treasury Shares as Restricted Stock Compensation

• 15 Feb.

  Manufactur麻雀 天 聖g and Market麻雀 天 聖g Approval for Three 麻雀 天 聖gredients and Eight Items

• 14 Feb.

  Notice of Acquisition of Approval for Application for Partial Change of Manufactur麻雀 天 聖g and Market麻雀 天 聖g Approval for Esomeprazole Capsules concern麻雀 天 聖g the Addition of a Manufactur麻雀 天 聖g Plant

• 13 Feb.

  Notice of Revisions of F麻雀 天 聖ancial Forecasts

• 13 Feb.

  FY2023(3rd quarter) Supplementary Material of F麻雀 天 聖ancial Results

• 13 Feb.

  Summary of Consolidated F麻雀 天 聖ancial Results for the N麻雀 天 聖e Months Ended December 31, 2023(Based on Japanese GAAP)

• 4 Jan.

  Updated IR Calendar